American Healthcare REIT Announces Launch of Public Offering
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
Molecular Partners to Present Additional Preclinical Data Supporting the Company’s Radio DARPins
FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
InteliChart Demonstrates Patient-Centric Technology at HIMSS23
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination ...
Popular News
